1GILARD M, ARNAUD B, CORNILY J C, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study[J]. J Am Coll Cardiol, 2008, 51: 256 - 260. 被引量：1
2RAY W A, MURRAY K T, GRIFFIN M R, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study[J].Ann Intern Med, 2010,152 : 337-345. 被引量：1
3ODONOGHUE M L, BRAUNWALD E, ANTMAN E M, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials[J].Lancet, 2009,374: 989-997. 被引量：1
4MEHTA S R, TANGUAY J F, EIKELBOOM J W, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7) : a randomised factorial trial[J]. Lancet, 2010,376,1233 -1243. 被引量：1
5BHATT D L, CRYER B L, CONTANT C F, et al. Clopidogrel with or without omeprazole in coronary artery disease[J]. N Engl J Med, 2010,363 : 1909 - 1917. 被引量：1
6LIMA J P, BROPHY J M. The potential interaction between clopidogrel and proton pump inhibitors: a systematie review[J]. BMC Med, 2010,8 : 81 - 81. 被引量：1
7ABRAHAM N S, HLATKY M A, ANTMAN E M, et al. ACCF/ACG/AHA 2010 Expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use[J]. J ACC, 2010,56 : 2051 - 2066. 被引量：1
3Fontana P,Bonvini RF,Roffi M,et al.Evaluating the biologicalefficacy of clopidogrel:genotype or phenotype[J].Rev Med Suisse,2010,6(235):302. 被引量：1
4Kim KA,Park PW,Hong SJ,et al.The effect of CYP2-C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel:a possible mechanism for clopidogrel resistance[J].Clin Pharmacol Ther,2008,84(2):236. 被引量：1
5Gerson LB,Triadafilopoulos G.Proton pump inhibitors and their drug interactions:an evidence-based approach[J].Eur J Gastroenterol Hepatol,2001,13(5):611. 被引量：1
6Li XQ,Andersson TB,Ahlstr?m M,et al.Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole,esomeprazole,lansoprazole,pantoprazole,and rabeprazole on human cytochrome P450 activities[J].Drug Metab Dispos,2004,32(8):821. 被引量：1
7Juurlink DN,Gomes T,Ko DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].CMAJ,2009,180(7):713. 被引量：1
9Bhatt DL,Flather MD,Hacke W,et al.Patients with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial[J].J Am Coll Caridiol,2007,49(19):1 982. 被引量：1
10Djener H,Bogousslavsky J,Bmss L,et al.Aspin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients(MATCH):randomised,double-blind,placebocontrolled trial[J].Lancet,2004,364(9 431):331. 被引量：1
